Zimmer Biomet Holdings (ZBH) closed at $94.98 on October 16, 2026, up 0.6% from the previous close, on volume of 1,486,805 shares (30-day average 2,010,972).
Data as of October 16, 2026.
16-Oct-2026
These S&P 500 stocks lead in capital efficiency - BofA
Seeking Alpha News (Fri, 16-Oct 12:14 PM ET)
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
PRNewswire (Tue, 13-Oct 7:31 AM ET)
Analysts’ Top Healthcare Picks: Cytek Biosciences (CTKB), Zimmer Biomet Holdings (ZBH)
TipRanks (Mon, 12-Oct 9:50 AM ET)
Leerink Partners Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH)
TipRanks (Mon, 12-Oct 7:38 AM ET)
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
PRNewswire (Tue, 6-Oct 7:30 AM ET)
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
PRNewswire (Tue, 8-Sep 4:30 PM ET)
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
PRNewswire (Fri, 28-Aug 4:15 PM ET)
Zimmer Biomet Raises 2026 Guidance after Solid Q2 Driven by Expanding Margins and Strong Cash Flow
Market Chameleon (Wed, 5-Aug 3:10 AM ET)
Zimmer Biomet Announces Second Quarter 2026 Financial Results
PRNewswire (Wed, 5-Aug 6:30 AM ET)
Zimmer Biomet’s Q1 2026 Results Show Strong Product Momentum and Margin Expansion: Guidance Raised
Market Chameleon (Tue, 28-Apr 3:36 AM ET)
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Zimmer Biomet Holdings trades on the NYSE stock market under the symbol ZBH.
As of October 16, 2026, ZBH stock price climbed to $94.98 with 1,486,805 million shares trading.
ZBH has a beta of 0.36, meaning it tends to be less sensitive to market movements. ZBH has a correlation of 0.02 to the broad based SPY ETF.
ZBH has a market cap of $18.58 billion. This is considered a Large Cap stock.
Last quarter Zimmer Biomet Holdings reported $2 billion in Revenue and $2.07 earnings per share. This beat revenue expectation by $42 million and exceeded earnings estimates by $.06.
In the last 3 years, ZBH traded as high as $133.90 and as low as $79.12.
The top ETF exchange traded funds that ZBH belongs to (by Net Assets): VTI, VOO, VB, MOAT, VBR.
ZBH has underperformed the market in the last year with a return of -3.5%, while SPY returned +15.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ZBH shares. However, ZBH has outperformed the market in the last 3 month and 2 week periods, returning +5.6% and +7.9%, while SPY returned +1.4% and -0.1%, respectively. This indicates ZBH has been having a stronger performance recently.
ZBH support price is $92.69 and resistance is $96.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZBH shares will trade within this expected range on the day.
